Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Liver Transplantation 2023: Status Report, Current and Future Challenges
Norah A. Terrault, Claire Francoz, Marina Berenguer, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2150-2166
Open Access | Times Cited: 117
COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
Penghui Li, Ying Liu, Ziqi Cheng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113568-113568
Open Access | Times Cited: 42
SARS‐CoV‐2 Productively Infects Human Hepatocytes and Induces Cell Death
Chunkyu Ko, Cho‐Chin Cheng, Daniele Mistretta, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access | Times Cited: 1
Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?
Christoph G. Dietrich, Andreas Geier, Uta Merle
World Journal of Gastroenterology (2023) Vol. 29, Iss. 2, pp. 367-377
Open Access | Times Cited: 14
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
André L. Simão, Carolina Santos Palma, Laura Izquierdo‐Sánchez, et al.
JHEP Reports (2023) Vol. 5, Iss. 5, pp. 100697-100697
Open Access | Times Cited: 14
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
Hendrik Luxenburger, Robert Thimme
Gut (2023) Vol. 72, Iss. 9, pp. 1783-1794
Open Access | Times Cited: 13
The Impact and Evolution of COVID-19 on Liver Transplant Recipients Throughout the Pandemic “Waves” in a Single Center
Clara Fernández Fernández, Blanca Otero Torrón, Mercedes Bernaldo de Quirós Fernández, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 273-273
Open Access
COVID-19 and hepatic injury: Diversity and risk assessment
Fares E.M. Ali, Mostafa K Abd El-Aziz, Mahmoud Ali, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 3, pp. 425-449
Open Access | Times Cited: 12
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients
Sam M. Murray, Elisa Pose, Melanie Wittner, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 1, pp. 109-123
Open Access | Times Cited: 12
Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update
Cesare Miranda, Elena Garlatti, Andrea Da Porto, et al.
Archives of Medical Science - Atherosclerotic Diseases (2023) Vol. 8, Iss. 1, pp. 1-10
Open Access | Times Cited: 11
Global treatment rate and barriers to direct‐acting antiviral therapy: A systematic review and meta‐analysis of 146 studies and 1 760 352 hepatitis C virus patients
Vy H. Nguyen, Daniel Q. Huang, Michael H. Le, et al.
Liver International (2023) Vol. 43, Iss. 6, pp. 1195-1203
Closed Access | Times Cited: 11
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
Mykhailo Buchynskyi, Iryna Kamyshna, Valentyn Oksenych, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1072-1072
Open Access | Times Cited: 11
The Antiviral Efficacy and Safety of Azvudine in Hospitalized SARS‐CoV‐2 Infected Patients with Liver Diseases Based on a Multicenter, Retrospective Cohort Study
Junyi Sun, Mengzhao Yang, Guanyue Su, et al.
Advanced Science (2025)
Open Access
COVID-19 and Its Effects on the Hepatobiliary System: A Literature Review
Sariya Khan, Jumana Hussain Timraz, Nourah A. Al Ghamdi, et al.
Cureus (2025)
Open Access
NAFLD was independently associated with severe COVID-19 among younger patients rather than older patients: A meta-analysis
Ying Wang, Yadong Wang, Guangcai Duan, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 4, pp. e136-e139
Open Access | Times Cited: 17
COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications
Mohammad Tarique Imam, Ziyad S. Almalki, Abdullah R. Alzahrani, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110439-110439
Open Access | Times Cited: 10
Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines
В. Б. Гриневич, Л. Б. Лазебник, Yu. A. Kravchuk, et al.
Experimental and Clinical Gastroenterology (2023), Iss. 12, pp. 4-68
Open Access | Times Cited: 9
Liver biopsy for assessment of suspected drug‐induced liver injury in metabolic dysfunction‐associated steatohepatitis clinical trials: Expert consensus from the Liver Forum
Melissa Palmer, David E. Kleiner, Zachary Goodman, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 59, Iss. 2, pp. 201-216
Open Access | Times Cited: 9
Cirrhosis is an independent predictor for COVID-19 mortality: A meta-analysis of confounding cofactors-controlled data
Ying Wang, Mengke Hu, Haiyan Yang
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. e28-e31
Open Access | Times Cited: 14
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination
Riccardo Nevola, Livio Criscuolo, Domenico Beccia, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 5, pp. 800-814
Open Access | Times Cited: 8
Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury
Hikmet Akkız
Viruses (2023) Vol. 15, Iss. 6, pp. 1287-1287
Open Access | Times Cited: 7
Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients
Alfredo Papa, Marcello Covino, Sara Sofia De Lucia, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 26, pp. 4099-4119
Open Access | Times Cited: 7
Immunogenicity and risk factors for poor humoral immune response to SARS-CoV-2 vaccine in patients with autoimmune hepatitis: a systematic review and meta-analysis
Zhaoxu Tian, Yonghua Chen, Yingxin Yao, et al.
Revista Española de Enfermedades Digestivas (2024)
Open Access | Times Cited: 2
Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination
Anand V. Kulkarni, Margarita Anders, Leyla Nazal, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. e60-e61
Open Access | Times Cited: 11
Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis
Hsin-Yun Wu, Tung‐Hung Su, Chun‐Jen Liu, et al.
Journal of the Formosan Medical Association (2023) Vol. 123, Iss. 1, pp. 88-97
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top